Posterolateral Lumbar Intertransverse Process Spine Arthrodesis With Recombinant Human Bone Morphogenetic Protein 2/Hydroxyapatite‐Tricalcium Phosphate After Laminectomy in the Nonhuman Primate

Study Design. A nonhuman primate lumbar intertransverse process arthrodesis model was used to evaluate recombinant human bone morphogenetic protein 2 (rhBMP‐2) in a hydroxyapatite‐tricalcium phosphate (HA‐ TCP) carrier as a complete bone graft substitute. Objectives. To assess the ability of a ceramic material to serve as a carrier for various doses of rhBMP‐2 as a bone graft substitute in a primate model of posterolateral intertransverse process spinal fusion after laminectomy. Summary of Background Data. The reported nonunion rates for posterolateral lumbar spine fusion with autogenous iliac crest bone range from 5‐35%. Recombi nant human bone morphogenetic protein 2 has shown potential to serve as a bone graft substitute for postero lateral intertransverse process spine fusion. Although a resorbable collagen sponge was a suitable carrier in rabbits and dogs, it was too compressible for the paraspinal muscles in rhesus monkeys. This failure of the collagen carrier has prompted evaluation of the feasibility of an alternative carrier material and the required dose of rhBMP‐2. Methods. Twenty‐one adult rhesus monkeys underwent a laminectomy at L4‐L5 followed by bilateral intertransverse process arthrodesis via the same midline incision (n = 16) or a minimally invasive video‐assisted posterolateral approach (n = 5). Bone graft implants on each side consisted of either 5 cm3 of autogenous iliac crest bone or 60:40 HA‐TCP blocks (1.2 × 0.5 × 3.7 cm) loaded with a solution containing 0, 6, 9, or 12 mg of rhBMP‐2 per side. The monkeys were killed 24 weeks after surgery. Inspection, manual palpation, radiography, and histology were used to assess fusion and to detect any bony growth into the laminectomy defect. Results. Fusion was not achieved in any of the monkeys treated with autogenous iliac crest bone graft. Both of the monkeys treated with the HA‐TCP blocks with 0 mg rhBMP‐2 achieved fusion. All 15 monkeys treated with the HA‐TCP blocks and either of the three doses of rhBMP‐2 achieved solid fusion. Two animals had extension of the fusion on one side because of malpositioned ceramic block. The results in animals fused via the minimally invasive video‐assisted technique were the same as inthose fused with the open technique. Histologic analysis showed some ingrowth of bone into the ends but not‐through the ceramic block in the absence of rhBMP‐2. When the ceramic blocks were loaded with rhBMP‐2 there was a dose‐dependent increase in the amount and quality of bone throughout the ceramic carrier based on qualitative assessment. No significant bone encroachment on the exposed thecal sac through the laminectomy defect was observed in any of the monkeys. Conclusion. Hydroxyapatite‐tricalcium phosphate proved to be a suitable carrier for rhBMP‐2 in the posterolateral spine fusion model in rhesus monkeys. Even in the presence of a laminectomy defect, there was no evidence of bone induction outside the confines of the ceramic carrier.

[1]  M. Marone,et al.  Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety. , 1999, Journal of spinal disorders.

[2]  J. Le Huec,et al.  Tri-calcium phosphate ceramics and allografts as bone substitutes for spinal fusion in idiopathic scoliosis as bone substitutes for spinal fusion in idiopathic scoliosis: comparative clinical results at four years. , 1997, Acta orthopaedica Belgica.

[3]  J M Toth,et al.  Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein-2 Without Decortication of Osseous Elements , 1997, Spine.

[4]  W. Hutton,et al.  In vivo evaluation of a resorbable osteoinductive composite as a graft substitute for lumbar spinal fusion. , 1997, Journal of spinal disorders.

[5]  S. Boden,et al.  Video‐Assisted Lateral Intertransverse Process Arthrodesis: Validation of a New Minimally Invasive Lumbar Spinal Fusion Technique in the Rabbit and Nonhuman Primate (Rhesus) Models , 1996, Spine.

[6]  R. Delamarter,et al.  Effective Doses of Recombinant Human Bone Morphogenetic Protein‐2 in Experimental Spinal Fusion , 1996, Spine.

[7]  J. Michael Kabo,et al.  Evaluation of rhBMP‐2 With an OPLA Carrier in a Canine Posterolateral (Transverse Process) Spinal Fusion Model , 1995, Spine.

[8]  W C Hutton,et al.  The Use of an Osteoinductive Growth Factor for Lumbar Spinal Fusion: Part II Study of Dose, Carrier, and Species , 1995, Spine.

[9]  W. Hutton,et al.  The Use of an Osteoinductive Growth Factor for Lumbar Spinal Fusion: Part I Biolog of Spinal Fusion , 1995 .

[10]  W. Hutton,et al.  Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein‐2 , 1995, Spine.

[11]  W C Hutton,et al.  An Experimental Lumbar Intertransverse Process Spinal Fusion Model: Radiographic, Histologic, and Biomechanical Healing Characteristics , 1995, Spine.

[12]  P. Guigui,et al.  Experimental Model of Posterolateral Spinal Arthrodesis in Sheep: Part 1. Experimental Procedures and Results With Autologous Bone Graft , 1994, Spine.

[13]  F Lavaste,et al.  Experimental Model of Posterolateral Spinal Arthrodesis in Sheep: Part 2. Application of the Model Evaluation of Vertebral Fusion Obtained With Coral (Porites) or With a Biphasic Ceramic (Triosite) , 1994, Spine.

[14]  G. Muschler,et al.  Evaluation of Human Bone Morphogenetic Protein 2 in a Canine Spinal Fusion Model , 1994, Clinical orthopaedics and related research.

[15]  H N Herkowitz,et al.  Pseudarthrosis of the spine. , 1992, Clinical orthopaedics and related research.

[16]  A. Reddi,et al.  Osteogenin, a bone morphogenetic protein, adsorbed on porous hydroxyapatite substrata, induces rapid bone differentiation in calvarial defects of adult primates. , 1992, Plastic and reconstructive surgery.

[17]  A. Reddi,et al.  Induction of Bone in Composites of Osteogenin and Porous Hydroxyapatite in Baboons , 1992, Plastic and reconstructive surgery.

[18]  U. Ripamonti,et al.  The morphogenesis of bone in replicas of porous hydroxyapatite obtained from conversion of calcium carbonate exoskeletons of coral. , 1991, The Journal of bone and joint surgery. American volume.

[19]  D. Weisman,et al.  Investigation of a hydroxyapatite and calcium sulfate composite supplemented with an osteoinductive factor. , 1990, Journal of biomedical materials research.

[20]  N Passuti,et al.  Macroporous calcium phosphate ceramic performance in human spine fusion. , 1989, Clinical orthopaedics and related research.

[21]  B Kerebel,et al.  Transformation of biphasic calcium phosphate ceramics in vivo: ultrastructural and physicochemical characterization. , 1989, Journal of biomedical materials research.

[22]  J. Osborn,et al.  The material science of calcium phosphate ceramics. , 1980, Biomaterials.

[23]  A. Depalma,et al.  The nature of pseudarthrosis. , 1968, Clinical orthopaedics and related research.

[24]  J. Steinmann Pseudoarthrosis of the spine , 1992 .